Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amber Moser

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Toxicologic Pathology|January 20, 2025
Myelin Methods: A Mini-ReviewBrad Bolon, Amber Moser, Elizabeth Chlipala
Stem Cell Research|April 13, 2015
Assessing reproductive toxicity of two environmental toxicants with a novel in vitro human spermatogenic modelCharles A Easley, Joshua M Bradner, Amber Moser, et al.
Toxicologic Pathology|May 31, 2025
Neuromethods: Basic Techniques for Evaluating the Nervous System in Nonclinical StudiesDeepa B Rao, Xavier Palazzi, Alexandra Duetting, et al.
Microbiology Spectrum|July 9, 2024
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxisJessica M Fogel, Estelle Piwowar-Manning, Amber Moser, et al.
Open Forum Infectious Diseases|November 3, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P Moore, Jessica M Fogel, Mark A Marzinke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083Raphael J Landovitz, Jessica M Fogel, Fei Gao, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2023
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Jessica M Fogel, Zhe Wang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Toxicologic Pathology|January 20, 2025
Myelin Methods: A Mini-ReviewBrad Bolon, Amber Moser, Elizabeth Chlipala
Stem Cell Research|April 13, 2015
Assessing reproductive toxicity of two environmental toxicants with a novel in vitro human spermatogenic modelCharles A Easley, Joshua M Bradner, Amber Moser, et al.
Toxicologic Pathology|May 31, 2025
Neuromethods: Basic Techniques for Evaluating the Nervous System in Nonclinical StudiesDeepa B Rao, Xavier Palazzi, Alexandra Duetting, et al.
Microbiology Spectrum|July 9, 2024
Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxisJessica M Fogel, Estelle Piwowar-Manning, Amber Moser, et al.
Open Forum Infectious Diseases|November 3, 2025
Sustained HIV Suppression With Co-formulated Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir in a Person With Transmitted Dolutegravir Resistance and Pretreatment Resistance to Lamivudine: a Case Report From HPTN 083Hannah P Moore, Jessica M Fogel, Mark A Marzinke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2026
Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083Raphael J Landovitz, Jessica M Fogel, Fei Gao, et al.
Antimicrobial Agents and Chemotherapy|March 30, 2023
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083Mark A Marzinke, Jessica M Fogel, Zhe Wang, et al.
Pageof 1